| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |